These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
309 related items for PubMed ID: 12698084
21. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C. Abdelmalek MF, Firpi RJ, Soldevila-Pico C, Reed AI, Hemming AW, Liu C, Crawford JM, Davis GL, Nelson DR. Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857 [Abstract] [Full Text] [Related]
22. Types of human leukocyte antigen and decrease in HCV core antigen in serum for predicting efficacy of interferon-Alpha in patients with chronic hepatitis C: analysis by a prospective study. Muto H, Tanaka E, Matsumoto A, Yoshizawa K, Kiyosawa K, Nagano Interferon Treatment Research Group. J Gastroenterol; 2004 Jul; 39(7):674-80. PubMed ID: 15293139 [Abstract] [Full Text] [Related]
24. A pilot study of combination therapy with initial high-dose interferon and amantadine hydrochloride for patients with chronic hepatitis C with the genotype 1b virus. Uyama H, Enomoto H, Kishima Y, Yamamoto M, Yoshida K, Okuda Y, Hirotani T, Kuroda T, Ito H, Matsuda M, Terabayashi M, Noguchi S, Kawase I, Nakamura H. Hepatogastroenterology; 2003 Jul; 50(54):2112-6. PubMed ID: 14696476 [Abstract] [Full Text] [Related]
26. Long-term results with interferon therapy in chronic type B hepatitis: a prospective randomized trial. Mazzella G, Saracco G, Festi D, Rosina F, Marchetto S, Jaboli F, Sostegni R, Pezzoli A, Azzaroli F, Cancellieri C, Montagnani M, Roda E, Rizzetto M. Am J Gastroenterol; 1999 Aug; 94(8):2246-50. PubMed ID: 10445557 [Abstract] [Full Text] [Related]
27. [The assessment of the treatment of viral hepatitis C with interferon alpha in children with leukemias and lymphomas]. Pawelec K, Zielecka-Walewska B, Brojer E, Rokicka-Milewska R. Wiad Lek; 1998 Aug; 51 Suppl 4():243-6. PubMed ID: 10731976 [Abstract] [Full Text] [Related]
28. An open trial of interferon alfa recombinant for hepatitis C after liver transplantation: antiviral effects and risk of rejection. Féray C, Samuel D, Gigou M, Paradis V, David MF, Lemonnier C, Reynès M, Bismuth H. Hepatology; 1995 Oct; 22(4 Pt 1):1084-9. PubMed ID: 7557855 [Abstract] [Full Text] [Related]
33. [Natural history, diagnosis and treatment of chronic hepatitis B and C in hemodialysis patients]. Nicolardi E, Grieco A, Rapaccini GL, Pompili M. G Ital Nefrol; 2010 Aug; 27(3):262-73. PubMed ID: 20540019 [Abstract] [Full Text] [Related]
35. Recombinant alpha-interferon in renal allograft recipients with chronic hepatitis C. Ozgür O, Boyacioğlu S, Telatar H, Haberal M. Nephrol Dial Transplant; 1995 Nov; 10(11):2104-6. PubMed ID: 8643176 [Abstract] [Full Text] [Related]
36. Thrombocytopenia in patients with HCV-positive chronic hepatitis: efficacy of leucocyte interferon-alpha treatment. Benci A, Caremani M, Tacconi D. Int J Clin Pract; 2003 Nov; 57(1):17-9. PubMed ID: 12587936 [Abstract] [Full Text] [Related]